Developing gossypol derivatives with enhanced antitumor activity X. S. LiangA. J. RogersC. C. Benz Preclinical studies Pages: 181 - 186
Effects of vinorelbine on epidermal growth factor-receptor binding of human breast cancer cell linesin vitro H. DepenbrockA. ShirvaniA. -R. Hanauske OriginalPaper Pages: 187 - 193
Comparative efficacy of DMP 840 against mouse and human solid tumor models Patricia LoRussoLisa DemchikThomas H. Corbett OriginalPaper Pages: 195 - 203
Phase I trial of ilmofosine as a 24 hour infusion weekly M. von MehrenB. J. GiantonioP. J. O'Dwyer OriginalPaper Pages: 205 - 210
A Phase I study of acivicin in refractory pediatric solid tumors Sylvain BaruchelMark BernsteinTeresa Vietti OriginalPaper Pages: 211 - 215
A phase II trial of paclitaxel (Taxol®) as first line treatment in advanced breast cancer Sandra M. SwainSusan F. HonigLinda Walton OriginalPaper Pages: 217 - 222
Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT) Avi I. EinzigStuart LipsitzAl. B. Benson III OriginalPaper Pages: 223 - 227
A Phase II trial of weekly infusional 5-fluorouracil in combination with lowdose leucovorin in patients with advanced colorectal cancer Naomi B. HaasRussell J. SchilderPeter J. O'Dwyer OriginalPaper Pages: 229 - 233
Phase II study of topotecan in metastatic hormone-refractory prostate cancer Gary R. HudesRichard KosierowskiBruce J. Giantonio OriginalPaper Pages: 235 - 240
A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinoma Robert S. WitteTraci LeongDonald L. Trump OriginalPaper Pages: 241 - 247
Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck Fred RosenEverett E. VokesAl. B. Benson III OriginalPaper Pages: 249 - 252
A Clinical Screening Cooperative Group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancer Marian DegardinJean Pierre ArmandHenri Roché OriginalPaper Pages: 253 - 255
Didemnin B in favourable histology non-Hodgkin's lymphoma G. GossA. MuldalW. P. Steward OriginalPaper Pages: 257 - 260
Cutaneous manifestations of taxol® therapy Charles J. Link Jr.Gisele A. SarosyEddie Reed Brief Report Pages: 261 - 263